| 1 |
34729926 | Pharmacological inhibition of epidermal growth factor receptor attenuates intracranial aneurysm formation by modulating the phenotype of vascular smooth muscle cells. | 2022 Jan |
4 |
| 2 |
34830377 | Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands. | 2021 Nov 19 |
3 |
| 3 |
32817373 | Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics. | 2020 Aug 18 |
2 |
| 4 |
33469545 | The Blockade of TACE-Dependent EGF Receptor Activation by Losartan-Erlotinib Combination Attenuates Renal Fibrosis Formation in 5/6-Nephrectomized Rats Under Vitamin D Deficiency. | 2020 |
1 |
| 5 |
30461012 | Upregulation of transient receptor potential melastatin 6 channel expression by rosiglitazone and all-trans-retinoic acid in erlotinib-treated renal tubular epithelial cells. | 2019 Jun |
2 |
| 6 |
28992288 | Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney. | 2018 Apr 1 |
1 |
| 7 |
29157977 | Cell type-specific pharmacological kinase inhibition for cancer chemoprevention. | 2018 Feb |
1 |
| 8 |
30116910 | Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats. | 2018 Aug 16 |
2 |
| 9 |
28506758 | Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy. | 2017 Aug 15 |
1 |
| 10 |
26423803 | Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis. | 2016 Jun |
1 |
| 11 |
27317889 | Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney. | 2016 Aug 1 |
1 |
| 12 |
25343568 | EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade. | 2015 Jan |
1 |
| 13 |
24445976 | Oral erlotinib, but not rapamycin, causes modest acceleration of bladder and hindlimb recovery from spinal cord injury in rats. | 2014 Mar |
2 |
| 14 |
25390346 | Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats. | 2014 |
3 |
| 15 |
23349960 | Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats. | 2013 |
2 |
| 16 |
22048644 | Cypermethrin induces astrocyte apoptosis by the disruption of the autocrine/paracrine mode of epidermal growth factor receptor signaling. | 2012 Feb |
2 |
| 17 |
19850946 | Role of epidermal growth factor inhibition in experimental pulmonary hypertension. | 2010 Jan 15 |
1 |
| 18 |
20840671 | Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis. | 2010 Sep |
1 |
| 19 |
20192114 | Interstitial infusion of erlotinib in the rodent brain. | 2009 |
1 |
| 20 |
18216322 | EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. | 2008 Feb |
1 |
| 21 |
18471254 | Delay of tympanic membrane wound healing in rats with topical application of a tyrosine kinase inhibitor. | 2008 May-Jun |
2 |
| 22 |
18579641 | Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism. | 2008 Oct |
1 |
| 23 |
17255893 | Inhibition of epidermal growth factor receptor by erlotinib: wound healing of experimental tympanic membrane perforations. | 2007 Feb |
1 |